Fair Value (Tables)

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

Financial instruments measured at fair value on a recurring basis and their location within the accompanying consolidated financial statements are as follows:

	December 31, 2020
(in thousands)	Level 1		Level 2		Level 3		Total		Location on Balance Sheet
Assets:
Forward contract agreements	$	—	$	103	$	—	$	103	Prepaid expenses and other
Deferred compensation investments in cash surrender life insurance		—		16,796		—		16,796	Other assets
Total	$	—	$	16,899	$	—	$	16,899
Liabilities:
Deferred compensation plan liabilities	$	—	$	17,276	$	—	$	17,276	Other long-term liabilities
Interest rate swaps - current portion		—		3,693		—		3,693	Accrued expenses and other current liabilities
Interest rate swaps - long-term portion		—		7,234		—		7,234	Other long-term liabilities
Total	$	—	$	28,203	$	—	$	28,203

	December 31, 2019
(in thousands)	Level 1		Level 2		Level 3		Total		Location on Balance Sheet
Assets:
Forward contract agreements	$	—	$	733	$	—	$	733	Prepaid expenses and other
Deferred compensation investments in cash surrender life insurance		—		15,020		—		15,020	Other assets
Total	$	—	$	15,753	$	—	$	15,753
Liabilities:
Deferred compensation plan liabilities	$	—	$	14,855	$	—	$	14,855	Other long-term liabilities
Interest rate swaps - current portion		—		1,069		—		1,069	Accrued expenses and other current liabilities
Interest rate swaps - long-term portion		—		2,742		—		2,742	Long-term Liabilities: Other
Total	$	—	$	18,666	$	—	$	18,666